Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone

被引:34
作者
Gomi, Fumi [1 ]
Nishida, Kentaro [1 ]
Oshima, Yusuke [1 ]
Sakaguchi, Hirokazu [1 ]
Sawa, Miki [1 ]
Tsujikawa, Motokazu [1 ]
Tano, Yasuo [1 ]
机构
[1] Osaka Univ, Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan
关键词
D O I
10.1016/j.ajo.2006.10.050
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To assess short,term efficacy and safety of intravitreal bevacizumab injections for idiopathic choroidal neovascularization (CNV) refractory to posterior subtenon triamcinolone injections. DESIGN: Noncomparative, interventional case series. METHODS: Intravitreal bevacizumab was injected into 10 eyes with idiopathic CNV in which posterior subtenon triamcinolone injections were not efficacious for more than three months. The main outcome measures were changes in best-corrected visual acuity (BCVA), central retinal thickness (CRT), and fluorescein angiography findings before and after bevacizumab injection. RESULTS: After treatment, the BCVA improvement at one month (P = .029) continued to three months (P = .003). CRT decreased significantly (P < .001). Leakage from idiopathic CNV three months after treatment stopped in seven eyes, decreased in two, and continued in one. In one patient, conjunctival swelling developed after the injection but resolved and did not recur after another injection. No other complications developed. CONCLUSIONS: Intravitreal bevacizumab improves BCVA in eyes with idiopathic CNV refractory to triamcinolone.
引用
收藏
页码:507 / 510
页数:4
相关论文
共 7 条
[1]   Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization - One-year results from a prospective case series [J].
Chan, WM ;
Lam, DSC ;
Wong, TH ;
Lai, TYY ;
Kwok, AKH ;
Tam, BSM ;
Li, KKW .
OPHTHALMOLOGY, 2003, 110 (12) :2395-2402
[2]   The use of corticosteroids for choroidal neovascularisation in young patients [J].
Flaxel, CJ ;
Owens, SL ;
Mulholland, B ;
Schwartz, SD ;
Gregor, ZJ .
EYE, 1998, 12 (2) :266-272
[3]   Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females [J].
Postelmans, L ;
Pasteels, B ;
Coquelet, P ;
El Ouardighi, H ;
Verougstraete, C ;
Schmidt-Erfurth, U .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 138 (05) :803-808
[4]   Short-term safety and efficacy of intravitreal bevacizumab (avastin) for neovascular agerelated macular degeneration [J].
Rich, Ryan M. ;
Rosenfeld, Philip J. ;
Puliafito, Carmen A. ;
Dubovy, Sander R. ;
Davis, Janet L. ;
Flynn, Harry W., Jr. ;
Gonzalez, Serafin ;
Feuer, William J. ;
Lin, Richard C. ;
Lalwani, Geeta A. ;
Nguyen, Jackie K. ;
Kumar, Gaurav .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (05) :495-511
[5]   Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration [J].
Rosenfeld, PJ ;
Moshfeghi, AA ;
Puliafito, CA .
OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (04) :331-335
[6]   Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia [J].
Sakaguchi, H. ;
Ikuno, Y. ;
Gomi, F. ;
Kamei, M. ;
Sawa, M. ;
Tsujikawa, M. ;
Oshima, Y. ;
Kusaka, S. ;
Tano, Y. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (02) :161-165
[7]   Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration [J].
Spaide, Richard F. ;
Laud, Ketan ;
Fine, Howard F. ;
Klancnik, James M., Jr. ;
Meyerle, Catherine B. ;
Yannuzzi, Lawrence A. ;
Sorenson, John ;
Slakter, Jason ;
Fisher, Yale L. ;
Cooney, Michael J. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (04) :383-390